LEAP THERAPEUTICS, INC.

Analyst Reco. Leap Therapeutics, Inc.

Equities

LPTX

US52187K2006

Real-time Estimate Cboe BZX Other stock markets 10:53:20 2024-05-07 am EDT			5-day change	1st Jan Change
3.22 ^USD	0.00%		+4.35%	-21.95%

Apr. 10	Leap Therapeutics, Inc. announced that it expects to receive $39.998476 million in funding from Samsara BioCapital LLC, 683 Capital Management, LLC, Rock Springs Capital Management LP, Gilead Sciences, Inc., Laurion Capital Management LP	CI
Mar. 19	Baird Adjusts Price Target on Leap Therapeutics to $9 From $11, Maintains Outperform Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Adjusts Price Target on Leap Therapeutics to $9 From $11, Maintains Outperform Rating	Mar. 19	MT
Mizuho Securities Adjusts Price Target on Leap Therapeutics to $12 From $20, Maintains Buy Rating	Nov. 20	MT
Baird Lowers Price Target on Leap Therapeutics to $20 From $30, Maintains Outperform Rating	23-08-15	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $18.50 From $17, Maintains Outperform Rating	23-07-13	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $17 From $20, Keeps Outperform Rating	23-06-23	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $2 From $2.50, Maintains Outperform Rating	23-03-27	MT
Mizuho Adjusts Price Target on Leap Therapeutics to $2 From $3, Maintains Buy Rating	23-03-17	MT
Mizuho Securities Adjusts Price Target on Leap Therapeutics to $3 From $6, Maintains Buy Rating	23-01-27	MT
HC Wainwright Lowers Price Target on Leap Therapeutics to $2.50 From $4, Maintains Buy Rating	23-01-18	MT
Raymond James Adjusts Price Target on Leap Therapeutics to $2.50 From $3.50, Maintains Outperform Rating	22-11-11	MT
Raymond James Adjusts Leap Therapeutics' Price Target to $3 from $4, Keeps Outperform Rating	22-07-13	MT
Piper Sandler Adjusts Leap Therapeutics' Price Target to $4 From $6, Reiterates Overweight Rating	22-05-31	MT
Piper Sandler Adjusts Leap Therapeutics' Price Target to $6 From $5, Reiterates Overweight Rating	22-01-24	MT
LEAP THERAPEUTICS : Mizuho Securities Starts Leap Therapeutics at Buy With $6 Price Target	21-10-04	MT
LEAP THERAPEUTICS : Raymond James Lifts Leap Therapeutics' Price Target to $4 from $3, Keeps Outperform Rating	21-09-14	MT
ANALYST RECOMMENDATIONS : American express, CrowdStrike, Five Below, J.M. Smucker, Lululemon...	21-06-07
LEAP THERAPEUTICS : Baird Starts Leap Therapeutics at Outperform with $5 Price Target	21-06-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW